California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on September 8, 2026

9 hours ago

Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development

Indeterminate GlobeNewswire

9 hours ago

Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics

Indeterminate GlobeNewswire

9 hours ago

Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

9 hours ago

CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

9 hours ago

Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)

Indeterminate GlobeNewswire

9 hours ago

Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics

Indeterminate GlobeNewswire

9 hours ago

Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

9 hours ago

BrainChild Bio Initiates Pivotal Phase 2 Trial for BCB-276 CAR T cell Therapy for DIPG, a Deadly Pediatric Brain Cancer

Indeterminate GlobeNewswire

9 hours ago

Cartesian Therapeutics Announces New Employment Inducement Grants

Indeterminate GlobeNewswire

9 hours ago

Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer

Indeterminate GlobeNewswire

9 hours ago

BrainChild Bio Closes $116 Million Series A Financing

Indeterminate GlobeNewswire

9 hours ago

Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis

Indeterminate GlobeNewswire

9 hours ago

NetraMark Appoints Former Global Atlantic Investment Office President and Scotiabank U.S. CEO Kevin Felix as Strategic Advisor

Indeterminate GlobeNewswire

9 hours ago

NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director

Indeterminate GlobeNewswire

9 hours ago

Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC

Indeterminate GlobeNewswire

9 hours ago

Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer

Indeterminate GlobeNewswire

9 hours ago

Newron Reports Subscription for EUR 5.5 Million of Shares by Investor Group as Part of Up to EUR 38 Million Total Financing to Advance Phase 3 Evenamide Program

Indeterminate GlobeNewswire

9 hours ago

Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer

Indeterminate GlobeNewswire

9 hours ago

Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026

Indeterminate GlobeNewswire

9 hours ago

NRx Pharmaceuticals to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire